Navigation Links
ETEX Corporation Announces Distribution Agreement With OrthoPediatrics Corp.
Date:1/26/2010

CAMBRIDGE, Mass., Jan. 26 /PRNewswire/ -- ETEX Corporation, an advanced biomaterials company, announced today a distribution agreement with OrthoPediatrics Corp., of Warsaw, Indiana. OrthoPediatrics will market and sell ETEX's nanocrystalline calcium phosphate on a non-exclusive basis in the United States and Canada.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20080424/NETH117LOGO )

The ETEX bone graft portfolio complements pediatric orthopedic and spine surgery as illustrated in the recent publication of positive pediatric outcomes using ETEX nanocrystalline calcium phosphate in the treatment of unicamaral bone cysts (Thawrani, et al. Journal of Pediatric Orthopaedics, Vol. 29, Num 5, pp. 511-517, 2009).

EquivaBone® is the first osteoinductive and osteoconductive product that is moldable, injectable and sets hard once implanted. A proprietary combination of ETEX's osteoconductive nanocrystalline calcium phosphate and osteoinductive Demineralized Bone Matrix (DBM), EquivaBone is indicated for use in posterolateral spine fusion. In addition, the osteoinductivity of the DBM is certified by lot in an in-vivo model, after sterilization, for the entirety of shelf life.

Beta-bsm® Injectable Paste and Gamma-bsm® Moldable Putty set hard with high compressive strength and provide an optimal osteoconductive scaffold for new bone growth. The nanocrystalline formulation mimics the chemical structure of human bone resulting in a predictable remodeling rate.

All three ETEX products are indication specific and intended for use in filling bone voids or defects of the skeletal system (including extremities, pelvis, and spine) that are not intrinsic to the stability of the bone structure. Beta-bsm can be injected to facilitate minimally invasive procedures. Gamma-bsm is a high strength moldable putty designed for use in filling large defects. EquivaBone targets slow healing fractures and defects where osteoinductivity is required.

Brian Ennis, President and CEO of ETEX Corporation, states: "We are pleased to announce the continued expansion of our global distribution network. Partnering with OrthoPediatrics will enable ETEX to focus on the traditionally underserved pediatric market segment. Our rapidly expanding product portfolio is an excellent complement to OrthoPediatrics' biologic and hardware initiatives."

About ETEX Corporation

Established in 1989, ETEX Corporation develops, manufactures and commercializes calcium phosphate-based biomaterials for improved orthopedic clinical outcomes. A leader in bioresorbable bone substitute materials, ETEX focuses on expanding applications through combinations with cells, biologics, or therapeutic agents delivered in minimally invasive and easy to use systems. For more information, visit www.etexcorp.com.

SOURCE ETEX Corporation

RELATED LINKS
http://www.etexcorp.com

'/>"/>

SOURCE ETEX Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. CEL-SCI Corporation Releases Letter to Shareholders
3. Alfacell Corporation to Present at UBS Global Life Sciences Conference
4. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
5. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
6. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
7. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
8. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
10. Immunosyn Corporation Releases SF-1019 Study Results
11. AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
Breaking Medicine Technology:
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
Breaking Medicine News(10 mins):